Evidence map›Paper›PMID 31116637›Full record

ArticleHuman vaccines & immunotherapeutics2019

Seroepidemiology of pertussis in Hangzhou, China, during 2009-2017.

Yuyang Xu, Erping Xu, Shijun Liu, Wei Zheng, Xuechao Zhang, Jian Du, Xiaoping Zhang, Jun Wang, Xinren Che, Wenwen Gu and 1 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuyang XuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Erping XuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Shijun LiuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Wei ZhengImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Xuechao ZhangImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Jian DuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Xiaoping ZhangImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Jun WangImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0001-6165-6220
Xinren CheImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Wenwen GuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Yan LiuImunoprevention institute, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Hangzhou Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, BacterialChildChild, PreschoolChinaDiphtheria-Tetanus-Pertussis VaccineFemaleHealthy VolunteersHumansImmunoglobulin GInfantInfant, NewbornMaleAntibodies, BacterialDiphtheria-Tetanus-Pertussis VaccineImmunoglobulin Gimmunological responsePertussisseroepidemiologyvaccine

Identifiers

PMID31116637
PMCPMC6930058
OpenAlexW2945998497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.